SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Mar-22 6:11 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Feb-22 | Grant | 10,400 | -- | -- | 48% 21.71K to 32.12K | |
04-Feb-22 4:57 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Feb-22 | Payment of Exercise | 742 | $45.03 | $33,412.30 | (3%) 22.46K to 21.71K | |
01-Feb-22 6:46 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 31-Jan-22 | Payment of Exercise | 210 | $45.94 | $9,647.40 | (< 1%) 22.67K to 22.46K | (14%) |
11-Jan-22 4:42 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-22 | Payment of Exercise | 90 | $50.63 | $4,556.70 | (< 1%) 22.76K to 22.67K | (4%) |
07-Jan-22 4:39 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-22 | Payment of Exercise | 1,511 | $50.69 | $76,592.60 | (6%) 24.27K to 22.76K | (1%) |